4//SEC Filing
Matis Louis 4
Accession 0001562180-19-001488
CIK 0001583648other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:25 PM ET
Size
5.6 KB
Accession
0001562180-19-001488
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-26+96,500→ 96,500 totalExercise: $3.09Exp: 2029-02-26→ Common Stock (96,500 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on February 26, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeother
Related Parties
1- filerCIK 0001650991
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:25 PM ET
- Size
- 5.6 KB